Braveheart Investment (GB:BRH) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Braveheart Investment Group has announced updates on two key portfolio companies, Kirkstall and Paraytec. Kirkstall has expanded its reach in the Chinese market with a new exclusive distribution agreement for its Quasi Vivo products, aimed at reducing the need for animal testing in drug safety assessments. Meanwhile, Paraytec has patented a method that significantly accelerates bacteria detection in human blood, offering potential for future royalty income through licensing to other manufacturers.
For further insights into GB:BRH stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue